| GCL Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement |
Globe Newswire |
03/23 |
08:00 |
| COMSTOCK RESOURCES, INC. ANNOUNCES SELECTION OF WESTERN HAYNESVILLE SITE TO HOST POWER GENERATION HUB |
Globe Newswire |
03/23 |
08:00 |
| Terra Innovatum Highlights Accelerating Progress Towards NRC Construction Permit and Expanding Commercial Opportunities in Updated Investor Presentation Ahead of ROTH Conference |
Globe Newswire |
03/23 |
08:00 |
| Cheer Holding Announces Fiscal Year 2025 Financial Results |
Globe Newswire |
03/23 |
08:00 |
| Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis |
Globe Newswire |
03/23 |
08:00 |
| Ormat Technologies, Inc. Announces Closing of Upsized $1 Billion Convertible Senior Notes Offering |
Globe Newswire |
03/23 |
08:00 |
| Pomerantz LLP announces: (I) PENDENCY OF CLASS ACTION AND PROPOSED SETTLEMENT; (II) SETTLEMENT FAIRNESS HEARING; AND (III) MOTION FOR AN AWARD OF ATTORNEYS’ FEES AND REIMBURSEMENT OF LITIGATION EXPENSES |
Globe Newswire |
03/23 |
08:00 |
| DRVN INVESTOR ALERT: Driven Brands Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law |
Globe Newswire |
03/23 |
07:45 |
| Bombardier Announces Successful Completion of Consent Solicitation with Respect to its 7.450% Notes due 2034 |
Globe Newswire |
03/23 |
07:30 |
| Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement |
Globe Newswire |
03/23 |
07:30 |
| Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update |
Globe Newswire |
03/23 |
07:30 |
| Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
03/23 |
07:30 |
| Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update |
Globe Newswire |
03/23 |
07:30 |
| Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851 |
Globe Newswire |
03/23 |
07:30 |
| Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease |
Globe Newswire |
03/23 |
07:30 |
| ASP Isotopes Completes Well Drilling Required for Phase 1 of Renergen Helium Project Four Months Ahead of Schedule |
Globe Newswire |
03/23 |
07:30 |
| Camping World Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – RGRD Law |
Globe Newswire |
03/23 |
07:20 |
| Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence |
Globe Newswire |
03/23 |
07:15 |
| WeRide Reports Record Full Year 2025 Revenue of RMB684.6 Million, Up 90% Year over Year |
Globe Newswire |
03/23 |
07:10 |
| IPG to Expand T20 Cricket Footprint Across Sri Lanka, Malaysia and Zimbabwe Following Merger with Flash Sports & Media, Inc., following Flash’s merger with NASDAQ-listed urban-gro, Inc. |
Globe Newswire |
03/23 |
07:05 |
| OR Royalties Appoints Mr. Patrick Godin to Its Board of Directors |
Globe Newswire |
03/23 |
07:03 |
| Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates |
Globe Newswire |
03/23 |
07:00 |
| TransAlta Investor Day Highlights Solid Foundation and Attractive Growth to 2029 and Beyond |
Globe Newswire |
03/23 |
07:00 |
| PyroGenesis’ Plasma-Based SPARC™ System Officially Unveiled at Launch of New Zealand’s National Refrigerant Destruction Facility |
Globe Newswire |
03/23 |
07:00 |
| Profile Products Names Michael Ranchino Chief Executive Officer |
Globe Newswire |
03/23 |
07:00 |
